Peer Review reports
From: TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma
Original Submission | ||
---|---|---|
28 Mar 2022 | Submitted | Original manuscript |
11 May 2022 | Reviewed | Reviewer Report |
9 Aug 2022 | Reviewed | Reviewer Report - Branislav Rovčanin |
20 Aug 2022 | Author responded | Author comments - Jiexian Jing |
Resubmission - Version 2 | ||
20 Aug 2022 | Submitted | Manuscript version 2 |
23 Aug 2022 | Author responded | Author comments - Jiexian Jing |
Resubmission - Version 3 | ||
23 Aug 2022 | Submitted | Manuscript version 3 |
24 Aug 2022 | Author responded | Author comments - Jiexian Jing |
Resubmission - Version 4 | ||
24 Aug 2022 | Submitted | Manuscript version 4 |
15 Sep 2022 | Reviewed | Reviewer Report |
17 Sep 2022 | Reviewed | Reviewer Report - Branislav Rovčanin |
7 Oct 2022 | Author responded | Author comments - Jiexian Jing |
Resubmission - Version 5 | ||
7 Oct 2022 | Submitted | Manuscript version 5 |
10 Oct 2022 | Author responded | Author comments - Jiexian Jing |
Resubmission - Version 6 | ||
10 Oct 2022 | Submitted | Manuscript version 6 |
20 Oct 2022 | Author responded | Author comments - Jiexian Jing |
Resubmission - Version 7 | ||
20 Oct 2022 | Submitted | Manuscript version 7 |
3 Nov 2022 | Reviewed | Reviewer Report |
Resubmission - Version 8 | ||
Submitted | Manuscript version 8 | |
Publishing | ||
7 Nov 2022 | Editorially accepted | |
16 Nov 2022 | Article published | 10.1186/s12902-022-01203-3 |
You can find further information about peer review here.